KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Capital Employed (2018 - 2025)

Amneal Pharmaceuticals (AMRX) has 5 years of Return on Capital Employed data on record, last reported at 0.11% in Q4 2024.

  • For Q4 2024, Return on Capital Employed changed N/A year-over-year to 0.11%; the TTM value through Dec 2024 reached 0.11%, changed N/A, while the annual FY2024 figure was 0.11%, 3.0% up from the prior year.
  • Return on Capital Employed reached 0.11% in Q4 2024 per AMRX's latest filing, up from 0.08% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.11% in Q4 2024 and bottomed at 0.03% in Q1 2020.
  • Average Return on Capital Employed over 4 years is 0.03%, with a median of 0.04% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: rose 6bps in 2021, then fell -8bps in 2022.
  • A 4-year view of Return on Capital Employed shows it stood at 0.03% in 2020, then surged by 248bps to 0.05% in 2021, then crashed by -166bps to 0.03% in 2022, then skyrocketed by 444bps to 0.11% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.11% in Q4 2024, 0.08% in Q3 2024, and 0.03% in Q4 2022.